维普期刊资源整合服务平台（V6.5）

326篇 您的检索式：作者名="Moiseyenko"

选中清除导出查看参考文献查看引证文献引用追踪共17页首页上一页第1页下一页末页 /17 跳转

	题名	作者	年代	出处	被引量
1	Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial显示文摘	Florian Lordick Yoon-Koo Kang Hyun-Cheol Chung Pamela Salman Sang Cheul Oh Gy?rgy Bodoky Galina Kurteva Constantin Volovat Vladimir M Moiseyenko Vera Gorbunova Joon Oh Park Akira Sawaki Ilhan Celik Heiko G?tte Helena Melezínková Markus Moehler	2013	Lancet Oncology2013，，6：	14
2	Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study显示文摘	J.A. Ajani M. Buyse M. Lichinitser V. Gorbunova G. Bodoky J.Y. Douillard S. Cascinu V. Heinemann R. Zaucha A. Carrato D. Ferry V. Moiseyenko	2013	European Journal of Cancer2013，，：	3
3	Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as fast-line therapy for advanced gastric cancer:a report of the V325 study group显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，24，31：	1
4	Randomised,phase Ⅱ trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines显示文摘	Talbot DC Moiseyenko V van Belle S	2002	Br J Cancer2002，86，：	1
5	Phase III studyof docetaxel and cisplatin plusfluorouracil compared with cisplatinand f\uorouraci\ as first-line therapyfor advanced gastric cancer: a reportof the V325 Study Group显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J ClinOncol''2006，24，31：	1
6	Phase Ⅲ study of docetaxel and cisplatin plus fluo-rouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group 显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，24，31：	1
7	Phase llI study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer: a report of the V325 Study Group 显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，24，31：	1
8	Capecitabine plus gemcitabine is an active combination for patients wit metastatic breast cancer reracry to antracyclines and taxanes显示文摘	Andres R Mayordomo JI Moiseyenko V	2002	J Clin Oncol2002，20，12：	1
9	Phase Ⅲ study of docetaxel and cisplatin plus fluomuracil compared with the 325 study Group 显示文摘	Van Custem E Moiseyenko VM Tjulandin S	2006	J Clin Onco12006，24，31：	1
10	Docetaxel when added to cisplatin-5-fluorouracil improves survival and maintains quality-of-life for a longer period in advanced gastric cancer:final results of a phase Ⅲ trial显示文摘	V Moiseyenko E Van Cutsem S Tjulandin	2005	EJC Supplements2005，3，2：	1
11	Phase I study of docetaxel and cisplatin plus fluorouracil com- pared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 StudyGroup显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，24，31：	1
12	Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group 显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，23，31：	1
13	KRAS status and efficacy in the first -line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience 显示文摘	Van Cutsem E Lang I D' haens G Moiseyenko V Zaluski J Fol- precht G	2008	J Gin Oncol2008，2620，2：	1
14	Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group显示文摘	VAN CUTSEM E MOISEYENKO V M TJULANDIN S	2006	J Clin Oncol2006，24，31：	1
15	Phase III study of docetaxel and eisplatin plus fluorouracil compared with cisplatin tin# fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group 显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，24，31：	1
16	Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer:a report of the V 325 Study Group显示文摘	Van Custem E Moiseyenko VM Tjulandin SA		0，，31：	1
17	Phase Ⅲ study of docetaxel and eisplatin plus fluorouracil compared with cisplatin and fluomuracil as first line therapy for advanced gastric cancer: a report of the V325 Study Group 显示文摘	Van Custem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，24，49：	1
18	Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group 显示文摘	Van Cutsem E Moiseyenko VM Tjulandin S	2006	J Clin Oncol2006，24，31：	1
19	Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with eisplatin and fluorouraeil in a phase I]I trial of advanced gastric or gastroesophageal cancer ade- nocareinoma:the V-325 Study Group显示文摘	Ajani JA Moiseyenko VM Tjulandin S	2007	J Clin Oneol2007，25，22：	1
20	Phase III study of docetaxel and cisplatin plus fluorouracil compared with 'cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group显示文摘	Cutsem EV Moiseyenko VM Tjulandin S	2007	Clin Oncol2007，25，17：	1

返回顶部每页显示：

共17页首页上一页第1页下一页末页 /17 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示